Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	January 2024 [Member]	August 2024 [Member]	Common Stock	Common Stock January 2024 [Member]	Common Stock August 2024 [Member]	Additional Paid In Capital	Additional Paid In Capital January 2024 [Member]	Additional Paid In Capital August 2024 [Member]	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Private Placement
Beginning Balance at Dec. 31, 2021	$ 459,638			$ 5			$ 689,275			$ (228,982)	$ (660)
Beginning Balance at Dec. 31, 2021				51,536,181
Exercise of Stock Options	3,154						3,154
Exercise of Stock Options, Shares				601,594
Vesting Restricted Stock, Shares				36,866
Stock-based compensation expense	35,480						35,480
Unrealized gain on marketable securities	(4,289)										(4,289)
Net Income (Loss)	(154,808)									(154,808)
Issuance of shares under ESPP	1,150						1,150
Issuance of shares under ESPP, Share				95,511
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance	0			$ 1			149,825					$ 149,826
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares				2,769,228
Ending Balance at Dec. 31, 2022	490,151			$ 6			878,884			(383,790)	(4,949)
Ending Balance, Shares at Dec. 31, 2022				55,039,380
Exercise of Stock Options	2,860						2,860
Exercise of Stock Options, Shares				441,759
Vesting Restricted Stock, Shares				39,511
Stock-based compensation expense	43,118						43,118
Unrealized gain on marketable securities	4,397										4,397
Net Income (Loss)	(146,962)									(146,962)
Issuance of shares under ESPP	1,407						1,407
Issuance of shares under ESPP, Share				64,655
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance	0
Ending Balance at Dec. 31, 2023	394,971			$ 6			926,269			(530,752)	(552)
Ending Balance, Shares at Dec. 31, 2023				55,585,305
Exercise of Stock Options	11,790						11,790
Exercise of Stock Options, Shares				799,117
Vesting Restricted Stock, Shares				174,463
Stock-based compensation expense	55,012						55,012
Unrealized gain on marketable securities	(933)										(933)
Net Income (Loss)	(223,858)									(223,858)
Issuance of shares under ESPP	2,018						2,018
Issuance of shares under ESPP, Share				97,164
Issuance of Common Stock and accompanying Pre-Funded Warrants at Private Placement, net of issuance	(301,373)	$ 301,373	$ 246,506			$ 1		$ 301,373	$ 246,505
Issuance of Common Stock and accompanying pre-funded warrants at Private Placement, net of issuance cost, shares					3,884,158	2,830,533
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs of $1.2 million	48,740						48,740
Issuance of common stock through At-The Market Sales Agreement, net of issuance costs of $1.2 million, shares				1,519,453
Ending Balance at Dec. 31, 2024	$ 835,619			$ 7			$ 1,591,707			$ (754,610)	$ (1,485)
Ending Balance, Shares at Dec. 31, 2024				64,890,193